Literature DB >> 28947706

GBA mutations in Gaucher type I Venezuelan patients: ethnic origins and frequencies.

Gilberto Gómez1, Sergio Arias, Leonor Cárdenas, Dalal Zoghbi, Irene Paradisi.   

Abstract

Gaucher disease (GD), the most frequent lysosomal storage disease, is caused by heterogeneous mutations in the locus coding for glucocerebrosidase (GBA). It is an autosomal recessive disorder with different phenotypes of which the most frequent is the nonneuronopathic or type 1, prevalent worldwide. To date, more than 430 mutations have been described, but their frequency distribution varies in different populations with four, N370S, L444P, IVS2 + 1G > A and 84insG, being the most frequent ones. In Venezuela, 20 unrelated index cases with GD type I were assessed for GBA mutation detection and for their in-phase haplotype identification, to gather genetic epidemiological data on the disease in the country and of its eventual ethnic origin. Ten missense mutations and two complex alleles were identified. The most frequent were N370S (42.5%), L444P (20%), IVS2+1G > A (10%) and R48W (5%); mutations R120W, P245H, H311R, R496H, W36X and R433G which were carried by a single chromosome each one. Three geographical foci were identified, displaying mutation heterogeneity. N370S had multiple genetic origins, different from the Ashkenazi's; a single common remote ancestor for this mutation in the country was dismissed, according to the haplotype analysis. All mutations have a likely European Caucasoid descent.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28947706     DOI: 10.1007/s12041-017-0821-8

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  23 in total

1.  Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.

Authors:  Irene Paradisi; Sergio Arias
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

2.  [Colombian haplotypes of the Gaucher disease-causing N370S mutation may originate from a possible common ancestral haplotype].

Authors:  Ricardo Wilches; Hugo Vega; Olga Echeverri; Luis Alejandro Barrera
Journal:  Biomedica       Date:  2006-09       Impact factor: 0.935

3.  Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.

Authors:  S P Peters; C J Coffee; R H Glew; R E Lee; D A Wenger; S C Li; Y T Li
Journal:  Arch Biochem Biophys       Date:  1977-09       Impact factor: 4.013

Review 4.  Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.

Authors:  D L Stone; N Tayebi; E Orvisky; B Stubblefield; V Madike; E Sidransky
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

6.  An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.

Authors:  L B Daniels; R H Glew; W F Diven; R E Lee; N S Radin
Journal:  Clin Chim Acta       Date:  1981-09       Impact factor: 3.786

7.  Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.

Authors:  E K Lau; N Tayebi; L J Ingraham; S L Winfield; V Koprivica; D L Stone; A Zimran; E I Ginns; E Sidransky
Journal:  Hum Genet       Date:  1999-04       Impact factor: 4.132

Review 8.  Mutation analysis of Gaucher disease patients from Argentina: high prevalence of the RecNciI mutation.

Authors:  B Cormand; T L Harboe; L Gort; C Campoy; M Blanco; N Chamoles; A Chabás; L Vilageliu; D Grinberg
Journal:  Am J Med Genet       Date:  1998-12-04

9.  Glucocerebrosidase processing in normal fibroblasts and in fibroblasts from patients with type I, type II, and type III Gaucher disease.

Authors:  E Beutler; W Kuhl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA.

Authors:  G S He; G A Grabowski
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

View more
  3 in total

1.  A rare homozygous p.Arg87Trp variant of the GBA gene in Gaucher disease: A case report.

Authors:  Houweyda Jilani; Faten Hsoumi; Imen Rejeb; Yasmina Elaribi; Syrine Hizem; Molka Sebai; Arndt Rolfs; Lamia Benjemaa
Journal:  Clin Case Rep       Date:  2022-05-12

Review 2.  Glucocerebrosidase mutations and Parkinson disease.

Authors:  Sophia R L Vieira; Anthony H V Schapira
Journal:  J Neural Transm (Vienna)       Date:  2022-08-06       Impact factor: 3.850

3.  Analysis of glucocerebrosidase (GBA) gene mutations in Iranian patients with Gaucher disease.

Authors:  Hadi Mozafari; Mohammad Tghikhani; Zohreh Rahimi; Asad Vaisi Raygani; Shahla Ansari; Shohreh Khatami; Mohammad Reza Alaei; Reza Saghiri
Journal:  Iran J Child Neurol       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.